Fulvestrant treatment alters MDM2 protein turnover and sensitivity of human breast carcinoma cells to chemotherapeutic drugs. (cinj.org)
Trastuzumab is a humanized monoclonal antibody that targets the HER2 receptor, which is overexpressed in approximately 20 — 30 % of human breast carcinomas [11]. (journals.plos.org)
Carlson BA, Dubay MM, Sausville EA, et al: Flavopiridol induces G1 arrest with inhibition of cyclin - dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. (cancernetwork.com)